PlexPress raises $2.8M to enhance gene expression

PlexPress, maker of technology that can measure which genes are being expressed and how in a given environment, has raised $2.75 million in seed funding to commercialize its lead product, called TRAC. Based in Los Altos, Calif., the company says this offering could rapidly accelerate certain types of genetic research, including diagnostic studies and drug development. And because it simplifies laboratory procedures, it could even cut costs.

The round of funding came from Conor Technology Fund, Veraventure, Helsinki University Fund and VTT. PlexPress says the market for products like TRAC should hit $1 billion in the next four years, making it a ripe investment opportunity now.

Next Story: Sustainable Energy catches $7.6M for solar inverters
Previous Story: Google Searchology: Search options, Google Squared and more